Home › Parkinson's Disease › Vermont › Burlington
Parkinson's Disease clinical trials in Burlington, VT
4 studies for Parkinson's Disease are looking for participants at sites in and around Burlington (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A US Study That Observes How Parkinson's Disease Changes Over Time in Patients Who Still Have Movement Symptoms Despite Taking Parkinson's Medications
RecruitingObservational study
- University of Vermont, Burlington
A Study to Evaluate the Efficacy and Safety of Intravenous (IV) Prasinezumab in Participants With Early-Stage Parkinson's Disease
RecruitingPhase 3
- University of Vermont Medical Center, Burlington
A Study to Investigate the Efficacy and Safety of Bemdaneprocel in Adults Who Have Parkinson's Disease
RecruitingPhase 3
- University of Vermont Medical Center, Burlington
Pyridostigmine for the Treatment of Constipation in Parkinson Disease
RecruitingPhase 2
- University of Vermont Medical Center, Burlington
About Parkinson's Disease
Parkinson's disease (PD) is a movement disorder. It causes tremors, stiffness, and slow movement. It gets worse over time. Learn what can help.
More about Parkinson's Disease on MedlinePlus
Parkinson's Disease trials in other cities
- New York City, NY23 studies
- Boston, MA19 studies
- Cleveland, OH18 studies
- Minneapolis, MN17 studies
- Nashville, TN15 studies
- Philadelphia, PA14 studies
- San Francisco, CA14 studies
- New Haven, CT14 studies
- Charleston, SC13 studies
- Farmington Hills, MI13 studies
- Chicago, IL13 studies
- Miami, FL13 studies
Other studies in Burlington
- Heart Failure8 studies
- Acute Myeloid Leukemia7 studies
- Cancer (all types)6 studies
- COPD5 studies
- Breast Cancer5 studies
- Leukemia4 studies
- Lung Cancer4 studies
- Cardiovascular Disease4 studies
- Cystic Fibrosis4 studies
- Non-Small Cell Lung Cancer4 studies
- Prostate Cancer4 studies
- Metastatic Cancer4 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.